A comparison between gemcitabine (GEM) and the matrix metalloproteinase (MMP) inhibitor BAY. 12-9566 in patients with advanced pancreatic cancer. - Moore,M.J.; Hamm,J.; Eisenberg,P.; Degenais,M.; Hagan,K.; Fiels,A.; Greenberg,B.; Schwartz,B.; Ottaway,J.; Zee,B.; Seymour,L. (Proc Am Soc Clin Oncol, 2000)